FDA — authorised 3 October 2013
- Application: NDA204508
- Marketing authorisation holder: BAXTER HLTHCARE CORP
- Status: supplemented
🇺🇸 Clinolipid in United States
FDA authorised Clinolipid on 3 October 2013
Marketing authorisations
FDA
- Status: approved
Other Metabolic approved in United States
Frequently asked questions
Is Clinolipid approved in United States?
Yes. FDA authorised it on 3 October 2013; FDA has authorised it.
Who is the marketing authorisation holder for Clinolipid in United States?
BAXTER HLTHCARE CORP holds the US marketing authorisation.